With Strong Safety Data For LibiGel, BioSante Raises $11.1 Million
This article was originally published in The Pink Sheet Daily
Executive Summary
Down to about $6 million at the end of the second quarter, the sexual health products firm uses a merger and private placement to significantly upgrade its cash position.